Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.41%
#4 aPriori aPriori +160.22%
#5 Bedrock Bedrock +74.34%
#6 Cysic Cysic +50.91%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.90%
#9 Bitway Bitway +28.95%
#10 COTI COTI +25.85%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

SNNAQ
Classifica tra le azioni #42234
Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm... Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm dedicated to discovering and advancing pharmaceutical treatments across diverse therapeutic fields. Its primary focus involved crafting therapies within immunology and inflammation, specifically targeting particular tissue pathways, notably in the skin. Among its pipeline, SNA-120 stood out as a pioneering, first-in-class inhibitor of tropomyosin receptor kinase A, undergoing Phase IIb clinical evaluation for addressing psoriasis and its associated itching. Another key candidate, SNA-125, a topical dual Janus kinase 3 inhibitor, progressed through Phase I/II clinical studies for conditions like atopic dermatitis, psoriasis, and pruritus. Furthermore, Sienna was advancing SNA-001, a topical suspension incorporating silver particles, into pivotal clinical trials not only for acne treatment but also for diminishing light-colored hair, encompassing shades such as white, gray, blonde, light brown, and light red. Established in 2010 and based in Westlake Village, California, the company originally operated as Sienna Labs, Inc. before rebranding as Sienna Biopharmaceuticals, Inc. in February 2016. However, the firm faced significant financial challenges, initiating Chapter 11 bankruptcy proceedings on September 16, 2019, which subsequently converted to Chapter 7 liquidation on December 18, 2019.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$3.09K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Sienna Biopharmaceuticals, Inc. (SNNAQ)

Categoria

Healthcare
Il prezzo SNNAQ con la capitalizzazione del mercato della B
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.0001
Capitalizzazione di mercato di Sienna Biopharmaceuticals, Inc.(SNNAQ)
Capitalizzazione di mercato: $3.09K
A partire dal August 2026, Sienna Biopharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $3.09K. Questo rende Sienna Biopharmaceuticals, Inc. la 42234th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Sienna Biopharmaceuticals, Inc. dal 2017 al 2026
SNNAQ in paragone con la classifica dei più popolari stocks
Il prezzo per SNNAQ Attivo B Capitalizzazione del mercato a B Risultati
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$174,162 $3.09K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +174,162,389,417.96%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$143,106 $3.09K
Apple Inc. Apple Inc.
AAPL
$4.423T +143,105,506,329.57%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$134,596 $3.09K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +134,596,227,628.31%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$118,516 $3.09K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +118,515,717,693.59%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$93,537.00 $3.09K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +93,537,003,956.94%